Gerhard Ehninger, Prof. Dr. med.

  • Chief Executive Officer at Cellex Gesellschaft für Zellgewinnung mbH, founding shareholder of GEMoaB Monoclonals GmbH, founding shareholder of Cellex Gesellschaft für Zellgewinnung mbH

  • Co-founder of the German Bone Marrow Donor Registry (DKMS)

  • Member of the Board of Directors at Rhön Klinikum AG

  • Speaker SFB 655 “From Cells to Tissues” (Collaborative Research Center for Stem Cell Research) 2005-2017

  • Former Head of Hematology & Oncology, University Hospital “Carl Gustav Carus”, Technical University Dresden, Germany

  • Former President of the German Society of Hematology and Oncology (DGHO)

  • More than 700 scientific publications in peer-reviewed journals



Michael Bachmann, Prof. Dr. rer. nat.

  • Founding shareholder of GEMoaB Monoclonals GmbH

  • Director of the Institute for Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Germany

  • Head of Radioimmunology, Helmholtz-Zentrum Dresden, Germany

  • Head of Tumor Immunology, University Cancer Center (UCC), University Hospital ‘Carl Gustav Carus‘, Technical University Dresden, Germany

  • Deputy Head of the Working Group Tumor Immunology of the German Society for Immunology (Deutsche Gesellschaft für Immunologie, DGfI)

  • More than 190 scientific publications in peer-reviewed journals


GEMoaB Management Team

Get to know us – About GEMoaB